Article
JMJD6 promotes radioresistance of non-small cell lung cancer via epigenetic regulation of EHF
2023-12-09
Abstract excerpt
Though radiation therapy (RT) is widely used in lung cancer at all stages for local tumor control, the long-term efficacy of radiotherapy is largely restricted by radioresistance as frequently observed in the clinical setting, eventually leading to cancer recurrence. With the advent of targeted therapies, we observed a dramatic uptick in the clinical outcomes of non–small cell lung cancer (NSCLC) patients. JMJD6 w...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 97c5990a-c873-5505-90bd-4581f2209afa
- DOI
- 10.21203/rs.3.rs-3717839/v1
